Common Contracts
8 similar Credit Agreement contracts by Horizon Pharma PLC, Horizon Therapeutics Public LTD Co
RECITALS:Credit Agreement • August 8th, 2023 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • Delaware
CREDIT AGREEMENT originally dated as of May 7, 2015 (as amended by Amendment No. 1, dated as of October 25, 2016, as further amended by Amendment No. 2, dated as of March 29, 2017, as further amended by Amendment No. 3, dated as of October 23, 2017, as further amended by Amendment No. 4, dated as of October 19, 2018, and as further amended by Amendment No. 5, dated as of March 11, 2019, as further amended by Amendment No. 6, dated as of May 22, 2019, as further amended by Amendment No. 7, dated as of December 18, 2019 and, as further amended by Amendment No. 8, dated as of August 17, 2020, as further amended by Amendment No. 9, dated as of March 15, 2021, and as further amended by Amendment No. 10, dated as of June 16, 2023, this “Agreement”), among HORIZON THERAPEUTICS USA, INC. (f/k/a Horizon Pharma USA, Inc.), a Delaware corporation (“HPUI”), HORIZON THERAPEUTICS PLC, an Irish public limited company (f/k/a Horizon Pharma Public Limited Company) (“Irish Holdco”), the Subsidiary Guara
AMENDMENT No. 9, dated as of March 15, 2021 (this “Amendment”), to the Credit Agreement, dated as of May 7, 2015, by and among Horizon Therapeutics USA, Inc., a Delaware corporation (the “Borrower”), Horizon Therapeutics plc, an Irish public limited...Credit Agreement • March 15th, 2021 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • Delaware
CREDIT AGREEMENT originally dated as of May 7, 2015 (as amended by Amendment No. 1, dated as of October 25, 2016, as further amended by Amendment No. 2, dated as of March 29, 2017, as further amended by Amendment No. 3, dated as of October 23, 2017, as further amended by Amendment No. 4, dated as of October 19, 2018, and as further amended by Amendment No. 5, dated as of March 11, 2019, as further amended by Amendment No. 6, dated as of May 22, 2019, as further amended by Amendment No. 7, dated as of December 18, 2019 and as further amended by Amendment No. 8, dated as of August 17, 2020, this “Agreement”), among HORIZON THERAPEUTICS USA, INC. (f/k/a Horizon Pharma USA, Inc.), a Delaware corporation (“HPUI”), HORIZON THERAPEUTICS PLC, an Irish public limited company (f/k/a Horizon Pharma Public Limited Company) (“Irish Holdco”), the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto and CITIBANK, N.A., as Administrative
AMENDMENT No. 7, dated as of December 18, 2019 (this “Amendment”), to the Credit Agreement, dated as of May 7, 2015, by and among Horizon Therapeutics USA, Inc., a Delaware corporation (the “Borrower”), Horizon Therapeutics plc, an Irish public...Credit Agreement • December 18th, 2019 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • New York
CREDIT AGREEMENT originally dated as of May 7, 2015 (as amended by Amendment No. 1, dated as of October 25, 2016, as further amended by Amendment No. 2, dated as of March 29, 2017, as further amended by Amendment No. 3, dated as of October 23, 2017, as further amended by Amendment No. 4, dated as of October 19, 2018, and as further amended by Amendment No. 5, dated as of March 11, 2019, and as further amended by Amendment No. 6, dated as of May 22, 2019, and as further amended by Amendment No. 7, dated as of December 18, 2019, this “Agreement”), among HORIZON PHARMATHERAPEUTICS USA, INC. (f/k/a Horizon Pharma USA, Inc.), a Delaware corporation (“HPUI”), HORIZON THERAPEUTICS PLC, an Irish public limited company (f/k/a Horizon Pharma Public Limited Company) (“Irish Holdco”), the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto and CITIBANK, N.A., as Administrative Agent and Collateral Agent.
AMENDMENT No. 6, dated as of May 22, 2019 (this “Amendment”), to the Credit Agreement, dated as of May 7, 2015, by and among Horizon Pharma USA, Inc., a Delaware corporation (the “Borrower”), Horizon Therapeutics plc, an Irish public limited company...Credit Agreement • May 22nd, 2019 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • New York
CREDIT AGREEMENT originally dated as of May 7, 2015 (as amended by Amendment No. 1, dated as of October 25, 2016, as further amended by Amendment No. 2, dated as of March 29, 2017, as further amended by Amendment No. 3, dated as of October 23, 2017, as further amended by Amendment No. 4, dated as of October 19, 2018, and as further amended by Amendment No. 5, dated as of March 11, 20182019, and as further amended by Amendment No. 6, dated as of May 22, 2019, this “Agreement”), among HORIZON PHARMA USA, INC., a Delaware corporation (“HPUI”), HORIZON PHARMA PUBLIC LIMITED COMPANYTHERAPEUTICS PLC, an Irish public limited company (f/k/a Horizon Pharma Public Limited Company) (“Irish Holdco”), the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto and CITIBANK, N.A., as Administrative Agent and Collateral Agent.
AMENDMENT No. 5, dated as of March 11, 2019 (this “Amendment”), to the Credit Agreement, dated as of May 7, 2015, by and among Horizon Pharma USA, Inc., a Delaware corporation (the “Borrower”), Horizon Pharma Public Limited Company, an Irish public...Credit Agreement • March 11th, 2019 • Horizon Pharma PLC • Pharmaceutical preparations • New York
CREDIT AGREEMENT originally dated as of May 7, 2015 (as amended by Amendment No. 1, dated as of October 25, 2016, as further amended by Amendment No. 2, dated as of March 29, 2017, as further amended by Amendment No. 3, dated as of October 23, 2017, and as further amended by Amendment No. 4, dated as of October 19, 2018, and as further amended by Amendment No. 5, dated as of March 11, 2018, this “Agreement”), among HORIZON PHARMA USA, INC., a Delaware corporation (“Horizon” or the “BorrowerHPUI”), HORIZON PHARMA PUBLIC LIMITED COMPANY, an Irish public limited company (“Irish Holdco”), HORIZON PHARMA USA, INC., a Delaware corporation (“HPUI”), the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto and CITIBANK, N.A., as Administrative Agent and Collateral Agent.
AMENDMENT No. 4, dated as of October 19, 2018 (this “Amendment”), to the Credit Agreement, dated as of May 7, 2015, by and among Horizon Pharma, Inc., a Delaware corporation (“Horizon” or the “Borrower”), Horizon Pharma USA, Inc. (“HPUI”), Horizon...Credit Agreement • October 19th, 2018 • Horizon Pharma PLC • Pharmaceutical preparations • New York
CREDIT AGREEMENT originally dated as of May 7, 2015 (as amended by Amendment No. 1, dated as of October 25, 2016, as further amended by Amendment No. 2, dated as of March 29, 2017, and as further amended by Amendment No. 3, dated as of October 23, 2017, and as further amended by Amendment No. 4, dated as of October 19, 2018, this “Agreement”), among HORIZON PHARMA, INC., a Delaware corporation (“Horizon” or the “Borrower”), HORIZON PHARMA PUBLIC LIMITED COMPANY, an Irish public limited company (“Irish Holdco”), HORIZON PHARMA USA, INC., a Delaware corporation (“HPUI”), the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto and CITIBANK, N.A., as Administrative Agent and Collateral Agent.
AMENDMENT No. 3, dated as of October 23, 2017 (this “Amendment”), to the Credit Agreement, dated as of May 7, 2015, by and among Horizon Pharma, Inc., a Delaware corporation (“Horizon” or the “Borrower”), Horizon Pharma USA, Inc. (“HPUI”), Horizon...Credit Agreement • October 23rd, 2017 • Horizon Pharma PLC • Pharmaceutical preparations • New York
CREDIT AGREEMENT originally dated as of May 7, 2015 (as amended by Amendment No. 1, dated as of October 25, 2016 and2016, as further amended by Amendment No. 2, dated as of March 29, 2017, and as further amended by Amendment No. 3, dated as of October 23, 2017, this “Agreement”), among HORIZON PHARMA, INC., a Delaware corporation (“Horizon” or the “Borrower”), HORIZON PHARMA PUBLIC LIMITED COMPANY, an Irish public limited company (“Irish Holdco”), HORIZON PHARMA USA, INC., a Delaware corporation (“HPUI”), the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto and CITIBANK, N.A., as Administrative Agent and Collateral Agent.
AMENDMENT No. 2, dated as of March 29, 2017 (this “Amendment”), to the Credit Agreement, dated as of May 7, 2015, by and among Horizon Pharma, Inc., a Delaware corporation (“Horizon” or the “Borrower”), Horizon Pharma USA, Inc. (“HPUI”), Horizon...Credit Agreement • March 30th, 2017 • Horizon Pharma PLC • Pharmaceutical preparations • New York
CREDIT AGREEMENT originally dated as of May 7, 2015 (as amended by Amendment No. 1, dated as of October 25, 2016 and as further amended by Amendment No. 2, dated as of March 29, 2017, this “Agreement”), among HORIZON PHARMA, INC., a Delaware corporation (“Horizon” or the “Borrower”), HORIZON PHARMA PUBLIC LIMITED COMPANY, an Irish public limited company (“Irish Holdco”), HORIZON PHARMA USA, INC., a Delaware corporation (“HPUI”), the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto and CITIBANK, N.A., as Administrative Agent and Collateral Agent.
